August 12, 2025

Insulin Infusion System

.

Client

Insulet Corporation (PODD) – Prior to IPO

Project Scope

Impact ES–Rhode Island was engaged by Insulet, then a startup with a groundbreaking concept for diabetes management, to develop the user interface and embedded software for their Personal Diabetes Monitor (PDM)—the handheld component of the Omnipod Insulin Management System.

Challenge

Insulet’s vision was to create the first insulin delivery system that completely concealed the pump from public view. The system included a handheld PDM that communicated wirelessly with a disposable, self-adhesive insulin pump, which held a three-day supply of insulin. The challenge was to design an intuitive, robust user interface and embedded control software that could be developed rapidly—even before hardware was available, and still meet FDA regulatory requirements for a Class II medical device.

Solution

Impact ES–Rhode Island engineers worked closely with Insulet to define the look, feel, and functionality of the Omnipod interface. Using an iterative process, the team developed LCD screen layouts and refined workflows for both users and clinicians.

Impact ES–Rhode Island developed the software for the reusable remote controller, which included:

  • Refinement of the remote’s user interface

  • Authoring the first Software Requirements Specification

  • Designing the remote’s custom operating system

  • Implementing the full application in C

  • Performing hardware hazards analysis

    • Developing comprehensive FDA documentation, including:

    • Design specifications

    • Unit testing scripts and execution

    • Documented code reviews

    • Requirements traceability

To facilitate development ahead of hardware availability, Impact ES–Rhode Island created a Windows-based simulator (SimGUI) of the remote controller. This simulation tool featured a graphical “skin” that mirrored the look and operation of the device. It allowed Insulet’s marketing team to test and demonstrate the user interface to investors and board members early in the development process.

Outcome

The result was a highly functional and user-friendly handheld controller that enabled Insulet to bring the first fully concealed, wireless insulin delivery system to market. The system has since become the foundation for the widely adopted Omnipod platform.

Key Takeaways

Impact ES–Rhode Island played a critical role in transforming Insulet’s vision into a commercial success. The collaboration delivered not only a robust embedded software solution but also FDA-compliant documentation and development tools that supported product demonstration, funding, and rapid iteration. The Omnipod system remains a market leader, and Impact ES–Rhode Island continues to support Insulet with ongoing software and documentation services.

Continued Reading